Cargando…
Exploration of the Potential Biomarkers of Papillary Thyroid Cancer (PTC) Based on RT(2) Profiler PCR Arrays and Bioinformatics Analysis
BACKGROUND: Papillary thyroid carcinoma (PTC) has increased rapidly over recent years, and radiation, hormone effects, gene mutations, and others were viewed as closely related. However, the molecular mechanisms of PTC have not been cleared. Therefore, we intended to screen more accurate key genes a...
Autores principales: | Peng, Ying, Zhang, Han-Wen, Cao, Wei-Han, Mao, Ying, Cheng, Ruo-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532047/ https://www.ncbi.nlm.nih.gov/pubmed/33061614 http://dx.doi.org/10.2147/CMAR.S266473 |
Ejemplares similares
-
Noninvasive encapsulated papillary RAS-like thyroid tumor (NEPRAS) or encapsulated papillary thyroid carcinoma (PTC)
por: Rosario, Pedro Weslley
Publicado: (2020) -
Intercellular adhesion molecule 1 is a sensitive and diagnostically useful immunohistochemical marker of papillary thyroid cancer (PTC) and of PTC-like nuclear alterations in Hashimoto's thyroiditis
por: ZHANG, KE, et al.
Publicado: (2016) -
RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
por: Romei, Cristina, et al.
Publicado: (2012) -
TIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC)
por: Jia, Wenyu, et al.
Publicado: (2018) -
MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma: the PTC-MA assay
por: Pesenti, Chiara, et al.
Publicado: (2017)